{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:19:24Z","timestamp":1776165564733,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.7759\/cureus.107009","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:54:08Z","timestamp":1776160448000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognosis and Treatment Approach for Stage 1 Retinal Angiomatous Proliferation Lesions: A Case Series With Long-Term Follow-Up"],"prefix":"10.7759","author":[{"given":"Dimitris","family":"Karagiannis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Bouratzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loukas","family":"Kontomichos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Batsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Paroikakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2017.01.008","article-title":"Retinal angiomatous proliferation","volume":"62","author":"Tsai AS","year":"2017","unstructured":"Tsai AS, Cheung N, Gan AT, Jaffe GJ, Sivaprasad S, Wong TY, Cheung CM. Retinal angiomatous proliferation. Surv Ophthalmol. 2017, 62:462-92. 10.1016\/j.survophthal.2017.01.008","journal-title":"Surv Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0b013e31823f9b3b","article-title":"Retinal angiomatous proliferation in age-related macular degeneration","volume":"32","author":"Yannuzzi LA","year":"2012","unstructured":"Yannuzzi LA, Negr\u00e3o S, Iida T, et al.. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2012, 32:416-34. 10.1097\/iae.0b013e31823f9b3b","journal-title":"Retina"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001268","article-title":"An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography","volume":"36","author":"Su D","year":"2016","unstructured":"Su D, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, Sarraf D. An updated staging system of type 3 neovascularization using spectral domain optical coherence tomography. Retina. 2016, 36:S40-9. 10.1097\/IAE.0000000000001268","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04306-1","article-title":"Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment","volume":"257","author":"Kim JH","year":"2019","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment. Graefes Arch Clin Exp Ophthalmol. 2019, 257:1183-9. 10.1007\/s00417-019-04306-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001383","article-title":"Recurrence in patients with type 3 neovascularization (retinal angiomatous proliferation) after intravitreal ranibizumab","volume":"37","author":"Kim JH","year":"2017","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW. Recurrence in patients with type 3 neovascularization (retinal angiomatous proliferation) after intravitreal ranibizumab. Retina. 2017, 37:1508-15. 10.1097\/IAE.0000000000001383","journal-title":"Retina"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S224319","article-title":"Predictive factors and long-term visual outcomes after anti-vascular endothelial growth factor treatment of retinal angiomatous proliferation","volume":"13","author":"Maruyama-Inoue M","year":"2019","unstructured":"Maruyama-Inoue M, Sato S, Yamane S, Kadonosono K. Predictive factors and long-term visual outcomes after anti-vascular endothelial growth factor treatment of retinal angiomatous proliferation. Clin Ophthalmol. 2019, 13:1981-9. 10.2147\/OPTH.S224319","journal-title":"Clin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.034","article-title":"Outcomes in eyes with retinal angiomatous proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)","volume":"123","author":"Daniel E","year":"2016","unstructured":"Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG. Outcomes in eyes with retinal angiomatous proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology. 2016, 123:609-16. 10.1016\/j.ophtha.2015.10.034","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181fe54c7","article-title":"Geographic atrophy in retinal angiomatous proliferation","volume":"31","author":"McBain VA","year":"2011","unstructured":"McBain VA, Kumari R, Townend J, Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina. 2011, 31:1043-52. 10.1097\/IAE.0b013e3181fe54c7","journal-title":"Retina"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041145","article-title":"Long-term treatment outcomes in type 3 neovascularization: focus on the difference in outcomes between geographic atrophy and fibrotic scarring","volume":"9","author":"Kim JH","year":"2020","unstructured":"Kim JH, Kim JW, Kim CG, Lee DW. Long-term treatment outcomes in type 3 neovascularization: focus on the difference in outcomes between geographic atrophy and fibrotic scarring. J Clin Med. 2020, 9:1145. 10.3390\/jcm9041145","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18837","article-title":"Geographic atrophy and activity of neovascularization in retinal angiomatous proliferation","volume":"57","author":"Baek J","year":"2016","unstructured":"Baek J, Lee JH, Kim JY, Kim NH, Lee WK. Geographic atrophy and activity of neovascularization in retinal angiomatous proliferation. Invest Ophthalmol Vis Sci. 2016, 57:1500-5. 10.1167\/iovs.15-18837","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.167627","article-title":"Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation","volume":"94","author":"Hemeida TS","year":"2010","unstructured":"Hemeida TS, Keane PA, Dustin L, Sadda SR, Fawzi AA. Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. Br J Ophthalmol. 2010, 94:701-5. 10.1136\/bjo.2009.167627","journal-title":"Br J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-2993-3","article-title":"Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation","volume":"254","author":"Cho HJ","year":"2016","unstructured":"Cho HJ, Lee TG, Han SY, et al.. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. 2016, 254:23-30. 10.1007\/s00417-015-2993-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001876","article-title":"Difference in treatment outcomes according to optical coherence tomography-based stages in type 3 neovascularization (retinal angiomatous proliferation)","volume":"38","author":"Kim JH","year":"2018","unstructured":"Kim JH, Chang YS, Kim JW, Kim CG, Lee DW, Cho SY. Difference in treatment outcomes according to optical coherence tomography-based stages in type 3 neovascularization (retinal angiomatous proliferation). Retina. 2018, 38:2356-62. 10.1097\/IAE.0000000000001876","journal-title":"Retina"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0172-2","article-title":"One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages","volume":"15","author":"Park YG","year":"2015","unstructured":"Park YG, Roh YJ. One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages. BMC Ophthalmol. 2015, 15:182. 10.1186\/s12886-015-0172-2","journal-title":"BMC Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-022-00521-y","article-title":"Three-year outcomes of intravitreal aflibercept injections for retinal angiomatous proliferation according to disease stage","volume":"11","author":"Huang YY","year":"2022","unstructured":"Huang YY, Lo WJ, Chang HY, Chou YB, Lin TC. Three-year outcomes of intravitreal aflibercept injections for retinal angiomatous proliferation according to disease stage. Ophthalmol Ther. 2022, 11:1503-16. 10.1007\/s40123-022-00521-y","journal-title":"Ophthalmol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02231-y","article-title":"Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes","volume":"37","author":"Mathis T","year":"2023","unstructured":"Mathis T, Holz FG, Sivaprasad S, et al.. Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes. Eye. 2023, 37:1758-65. 10.1038\/s41433-022-02231-y","journal-title":"Eye"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476660-prognosis-and-treatment-approach-for-stage-1-retinal-angiomatous-proliferation-lesions-a-case-series-with-long-term-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:54:11Z","timestamp":1776160451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476660-prognosis-and-treatment-approach-for-stage-1-retinal-angiomatous-proliferation-lesions-a-case-series-with-long-term-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.107009","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}